Cargando…

Secular Decreasing Trend in Plasma Eicosapentaenoic and Docosahexaenoic Acids among Patients with Acute Coronary Syndrome from 2011 to 2019: A Single Center Descriptive Study

Despite intensive lipid-lowering interventions, patients treated with statins develop atherosclerotic cardiovascular disease (ASCVD), and these patients have an increased risk of developing recurrent cardiovascular events during follow-up. Therefore, there is a need to focus on the residual risks in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Tomoaki, Miyoshi, Toru, Doi, Masayuki, Seiyama, Kosuke, Takagi, Wataru, Sogo, Masahiro, Nosaka, Kazumasa, Takahashi, Masahiko, Okawa, Keisuke, Ito, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829914/ https://www.ncbi.nlm.nih.gov/pubmed/33477264 http://dx.doi.org/10.3390/nu13010253

Ejemplares similares

Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure
por: Okada, Tomoaki, et al.
Publicado: (2023)

Lotus root‐like appearance in the left anterior descending artery treated with a drug‐coated balloon angioplasty
por: Takagi, Wataru, et al.
Publicado: (2022)

Effect of Early Initiation of Evolocumab on Lipoprotein(a) in Patients with Acute Myocardial Infarction: Sub-Analysis of a Randomized Controlled Trial
por: Okada, Tomoaki, et al.
Publicado: (2022)

Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention
por: Takagi, Wataru, et al.
Publicado: (2017)

A successful transfemoral transcatheter aortic valve replacement case with VIABAHN® VBX balloon‐expandable stent‐graft and long Dryseal sheath for challenging access route
por: Kawaguchi, Tomohiro, et al.
Publicado: (2023)

Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination
por: Oka, Akihiro, et al.
Publicado: (2022)

Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
por: Russell, Fraser D., et al.
Publicado: (2012)

Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells
por: Bate, Clive, et al.
Publicado: (2008)

Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells
por: Siddiqui, Rafat A, et al.
Publicado: (2005)

Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Muscle Damage and Function
por: Ochi, Eisuke, et al.
Publicado: (2018)

Successful coronary stent implantation using directional coronary atherectomy without side branch occlusion
por: Kawaguchi, Tomohiro, et al.
Publicado: (2023)

Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammation and oxidative stress
por: Bloomer, Richard, et al.
Publicado: (2009)

The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis
por: Avanoǧlu Güler, Aslıhan, et al.
Publicado: (2020)

Selective Consumption of Fish Oil at End of the Day Increases the Physiological Fatty Acid Compositions of Eicosapentaenoic Acid and Docosahexaenoic Acid in Mice
por: Matsuzaka, Hiroki, et al.
Publicado: (2022)

Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation
por: Wann, Angus KT, et al.
Publicado: (2010)

Formulation, Characterization and Optimization of Liposomes Containing Eicosapentaenoic and Docosahexaenoic Acids; A Methodology Approach
por: Hadian, Zahra, et al.
Publicado: (2014)

Docosahexaenoic acid, but not eicosapentaenoic acid, improves septic shock-induced arterial dysfunction in rats
por: Boivin, Alexandra, et al.
Publicado: (2017)

Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?
por: Pal, Anandita, et al.
Publicado: (2020)

Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Chylomicron and VLDL Synthesis and Secretion in Caco-2 Cells
por: Wang, Yue, et al.
Publicado: (2014)

Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice
por: Soni, Nikul K, et al.
Publicado: (2015)

Eicosapentaenoic acid but not docosahexaenoic acid restores skeletal muscle mitochondrial oxidative capacity in old mice
por: Johnson, Matthew L, et al.
Publicado: (2015)

Eicosapentaenoic and Docosahexaenoic Acid-Enriched High Fat Diet Delays Skeletal Muscle Degradation in Mice
por: Soni, Nikul K., et al.
Publicado: (2016)

Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly
por: Titova, Olga E., et al.
Publicado: (2012)

The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review
por: Innes, Jacqueline K., et al.
Publicado: (2018)

Bioconversion From Docosahexaenoic Acid to Eicosapentaenoic Acid in the Marine Bacterium Shewanella livingstonensis Ac10
por: Ogawa, Takuya, et al.
Publicado: (2020)

Differential and shared effects of eicosapentaenoic acid and docosahexaenoic acid on serum metabolome in subjects with chronic inflammation
por: Chang, Wan-Chi, et al.
Publicado: (2021)

Common and differential effects of docosahexaenoic acid and eicosapentaenoic acid on helper T-cell responses and associated pathways
por: Lee, Jaeho, et al.
Publicado: (2021)

Lipid Structure Influences the Digestion and Oxidation Behavior of Docosahexaenoic and Eicosapentaenoic Acids in the Simulated Digestion System
por: Beltrame, Gabriele, et al.
Publicado: (2023)

Dietary Intake of Eicosapentaenoic and Docosahexaenoic Acid and Diabetic Nephropathy: Cohort Analysis of the Diabetes Control and Complications Trial
por: Lee, Cheetin C., et al.
Publicado: (2010)

Serum docosahexaenoic and eicosapentaenoic acid and risk of cognitive decline over 10 years among elderly Japanese
por: Otsuka, R, et al.
Publicado: (2014)

Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes
por: Labonté, Marie-Ève, et al.
Publicado: (2013)

Age Stratification and Impact of Eicosapentaenoic Acid and Docosahexaenoic Acid to Arachidonic Acid Ratios in Ischemic Stroke Patients
por: Ueno, Yuji, et al.
Publicado: (2018)

Plasma Docosahexaenoic Acid and Eicosapentaenoic Acid Concentrations Are Positively Associated with Brown Adipose Tissue Activity in Humans
por: Xiang, Angie S., et al.
Publicado: (2020)

Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
por: Zhuang, Pan, et al.
Publicado: (2021)

Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic Acids
por: Khan, Safi U., et al.
Publicado: (2021)

Erratum to: Common and differential effects of docosahexaenoic acid and eicosapentaenoic acid on helper T-cell responses and associated pathways
por: Lee, Jaeho, et al.
Publicado: (2021)

Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model
por: Sherratt, Samuel C. R., et al.
Publicado: (2023)

Secular Trends in Soda Consumption, California, 2011–2016
por: Lee, Matthew M., et al.
Publicado: (2019)

Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor‐dependent contractions of guinea pig gastric fundus smooth muscle
por: Xu, Keyue, et al.
Publicado: (2022)

Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Prostate Cancer Cell Migration and Invasion Induced by Tumor-Associated Macrophages
por: Li, Cheng-Chung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q8d50fdc2lb94h4sjcedfgljln